Abstract:MT‐2 cells, an immortalized regulatory T‐cell line, offer a model with which to study regulatory T cells (Treg) biology. We use clustered regularly interspaced palindromic repeats (CRISPR) to remove the master Treg transcriptional regulator [forkhead box P3 (FOXP3)] in MT‐2 cells and demonstrate that the loss of FOXP3 affects the transcriptome of MT‐2 cells. In addition, MT‐2 cells lacking FOXP3 expression have functional defects in suppressive activities, cell cycling and proliferation and expression of molecules crucial to Treg function. CD4+ forkhead box P3 (FOXP3)+ regulatory T cells (Tregs) are essential in maintaining immune tolerance and suppressing excessive immune responses. Tregs also contribute to tissue repair processes distinct from their roles in immune suppression. For these reasons, Tregs are candidates for targeted therapies for inflammatory and autoimmune diseases, and in diseases where tissue damage occurs. MT‐2 cells, an immortalized Treg‐like cell line, offer a model to study Treg biology and their therapeutic potential. In the present study, we use clustered regularly interspaced palindromic repeats (CRISPR)‐mediated knockdown of FOXP3 in MT‐2 cells to understand the transcriptional and functional changes that occur when FOXP3 is lost and to compare MT‐2 cells with primary human Tregs. We demonstrate that loss of FOXP3 affects the transcriptome of MT‐2 cells and that FOXP3's potential downstream targets include a wide range of transcripts that participate in the cell cycle, promote growth and contribute to inflammatory processes, but do not wholly simulate previously reported human primary Treg transcriptional changes in the absence of FOXP3. We also demonstrate that FOXP3 regulates cell cycling and proliferation, expression of molecules crucial to Treg function and MT‐2 cell–suppressive activities. Thus, MT‐2 cells offer opportunities to address regulatory T‐cell functions in vitro.

PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+)CD25(-) T cells to regulatory T-like cells.

Neuropilin-1 Identifies a New Subpopulation of TGF--Induced Foxp3<SUP>+</SUP> Regulatory T Cells With Potent Suppressive Function and Enhanced Stability During Inflammation

Identification and Characterization of Foxp3+ Γδ T Cells in Mouse and Human

Regulatory dendritic cells program generation of interleukin-4–producing alternative memory CD4 T cells with suppressive activity

Potential Regulatory Role of in Vitro-Expanded Vδ1 T Cells from Human Peripheral Blood

Human-engineered Treg-like cells suppress FOXP3-deficient T cells but preserve adaptive immune responses in vivo

Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3

FOXP3 and its role in the immune system

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

TRAF6 directs FOXP3 localization and facilitates regulatory T-cell function through K63-linked ubiquitination.

CD4+CD62L+ Central Memory T Cells Can Be Converted to Foxp3+ T Cells

Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.

PIM1 Kinase Phosphorylates the Human Transcription Factor FOXP3 at Serine 422 to Negatively Regulate Its Activity under Inflammation*

Abstract 4988: FOXP3, a Critical Mediator of Regulatory T-cell Function, is Expressed in Subsets of Myeloid Cells.

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity

Characterization of the MT‐2 Treg‐like cell line in the presence and absence of forkhead box P3 (FOXP3)

Human CD8+HLA-DR+ Regulatory T Cells, Similarly to Classical CD4+Foxp3+ Cells, Suppress Immune Responses via PD-1/PD-L1 Axis

FOXP3 and Its Partners: Structural and Biochemical Insights into the Regulation of FOXP3 Activity

DNA Methyltransferase Inhibitor Promotes Human CD4+CD25hFOXP3+ Regulatory T Lymphocyte Induction under Suboptimal TCR Stimulation

Functional and stable expression of recombinant human FOXP3 in bacterial cells and development of antigen-specific monoclonal antibodies.